The December 2025 phase 3 trial results showed even more impressive outcomes
When Lilly presented retatrutides early Phase 2 numbers at a medical conference in 2023, a scientist in the room told The Atlantic the usually staid audience broke into spontaneous applause
The mechanisms underlying these effects involve the modulation of signaling pathways associated with cell growth, survival, and metabolism
Among them, dimethyl biguanide (known as metformin) was selected for clinical development with the suggestive name of Glucophage, which means glucose eater. The other biguanides, phenformin and buformin, were more potent than metformin, however in the late 1970s they were removed in most countries because of their association with lactic acidosis (Seyfried et al., 2014
Anyone considering this protocol should review the safety section above and consult a qualified clinician
Hypertens Res 48 , 31593171 (2025)